MarketCap
Facebook
X
Telegram
Vivos Therapeutics Market Cap | VVOS
As of July 30, 2026 Vivos Therapeutics has a market cap of $ 4.32 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.1 M | 14.3 M | 5.89 M | 322 K | 70.9 B | 116 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.9 B | 322 K | 11.8 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M |  USA |
 |
Myomo
MYO
|
33.9 M | $ 0.93 | -3.11 % | $ 38.9 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
5.38 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Profound Medical Corp.
PROF
|
166 M | $ 7.24 | -0.14 % | $ 219 M |  Canada |
 |
AxoGen
AXGN
|
1.5 B | $ 41.37 | 0.53 % | $ 1.91 B | USA |
 |
Quanterix Corporation
QTRX
|
269 M | $ 3.38 | -3.15 % | $ 144 M | USA |
 |
AVITA Medical
RCEL
|
104 M | $ 4.44 | -3.69 % | $ 124 M |  Australia |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
602 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Bruker Corporation
BRKR
|
5.58 B | $ 61.74 | -1.86 % | $ 9.37 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Smith & Nephew plc
SNN
|
27.4 B | $ 32.66 | 0.31 % | $ 28.3 B |  Britain |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 27.4 | -1.23 % | $ 627 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M | Canada |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 18.59 | 4.67 % | $ 1.26 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 14.14 | -2.68 % | $ 400 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.86 | -1.95 % | $ 14.6 M | USA |
 |
Avanos Medical
AVNS
|
628 M | $ 24.99 | - | $ 1.16 B | USA |
 |
Viemed Healthcare
VMD
|
352 M | $ 11.65 | -2.27 % | $ 453 M | USA |
 |
Varex Imaging Corporation
VREX
|
502 M | $ 10.95 | -1.62 % | $ 453 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.35 | -4.32 % | $ 21.8 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.25 | -1.87 % | $ 62.8 M | USA |
 |
Beyond Air
XAIR
|
4.15 B | $ 5.51 | 0.92 % | $ 45.7 B | USA |
 |
NanoVibronix
NAOV
|
92 K | - | - | $ 1.08 M | USA |
 |
Xtant Medical Holdings
XTNT
|
78.1 M | $ 0.43 | 0.14 % | $ 60 M | USA |
 |
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
799 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
213 M | - | - | $ 217 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
16.3 B | $ 97.15 | 1.46 % | $ 19.2 B | USA |